AAAAAA

   
Results: 1-7 |
Results: 7
Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma - I. Visual acuity after 3 years - COMS report no. 16
Authors: Melia, BM Abramson, DH Albert, DM Boldt, HC Earle, JD Hanson, WF Montague, P Moy, CS Schachat, AP Simpson, ER Straatsma, BR Vine, AK Weingeist, TA
Citation: Bm. Melia et al., Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma - I. Visual acuity after 3 years - COMS report no. 16, OPHTHALMOL, 108(2), 2001, pp. 348-366
Recommendations of the American Association of Physicists in Medicine on Pd-103 interstitial source calibration and dosimetry: Implications for dose specification and prescription
Authors: Williamson, JF Coursey, BM DeWerd, LA Hanson, WF Nath, R Rivard, MJ Ibbott, G
Citation: Jf. Williamson et al., Recommendations of the American Association of Physicists in Medicine on Pd-103 interstitial source calibration and dosimetry: Implications for dose specification and prescription, MED PHYS, 27(4), 2000, pp. 634-642
AAPM's TG-51 protocol for clinical reference dosimetry of high-energy photon and electron beams
Authors: Almond, PR Biggs, PJ Coursey, BM Hanson, WF Huq, MS Nath, R Rogers, DWO
Citation: Pr. Almond et al., AAPM's TG-51 protocol for clinical reference dosimetry of high-energy photon and electron beams, MED PHYS, 26(9), 1999, pp. 1847-1870
Determination of the tissue attenuation factor along two major axes of a high dose rate (HDR) Ir-192 source
Authors: Cho, SH Muller-Runkel, R Hanson, WF
Citation: Sh. Cho et al., Determination of the tissue attenuation factor along two major axes of a high dose rate (HDR) Ir-192 source, MED PHYS, 26(8), 1999, pp. 1492-1497
Guidance to users of Nycomed Amersham and North American Scientific, Inc.,I-125 Interstitial Sources: Dosimetry and calibration changes: Recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on Low-Energy Seed Dosimetry
Authors: Williamson, JF Coursey, BM DeWerd, LA Hanson, WF Nath, R Ibbott, G
Citation: Jf. Williamson et al., Guidance to users of Nycomed Amersham and North American Scientific, Inc.,I-125 Interstitial Sources: Dosimetry and calibration changes: Recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on Low-Energy Seed Dosimetry, MED PHYS, 26(4), 1999, pp. 570-573
On the use of apparent activity (A(app)) for treatment planning of I-125 and Pd-103 interstitial brachytherapy sources: Recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee Subcommittee on Low-Energy Brachytherapy Source Dosimetry
Authors: Williamson, JF Coursey, BM DeWerd, LA Hanson, WF Nath, R Rivard, RJ Ibbott, G
Citation: Jf. Williamson et al., On the use of apparent activity (A(app)) for treatment planning of I-125 and Pd-103 interstitial brachytherapy sources: Recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee Subcommittee on Low-Energy Brachytherapy Source Dosimetry, MED PHYS, 26(12), 1999, pp. 2529-2530
Dosimetric prerequisites for routine clinical use of new low energy photoninterstitial brachytherapy sources
Authors: Williamson, J Coursey, BM DeWerd, LA Hanson, WF Nath, R
Citation: J. Williamson et al., Dosimetric prerequisites for routine clinical use of new low energy photoninterstitial brachytherapy sources, MED PHYS, 25(12), 1998, pp. 2269-2270
Risultati: 1-7 |